Nautilus Biotechnology, Inc. (NAUT) NASDAQ

0.83

+0.0067(+0.81%)

Updated at September 26 04:00PM

Currency In USD

Nautilus Biotechnology, Inc.

Address

2701 Eastlake Avenue East

Seattle, WA 98102

United States of America

Phone

206 333 2001

Sector

Healthcare

Industry

Biotechnology

Employees

134

First IPO Date

August 07, 2020

Key Executives

NameTitlePayYear Born
Mr. Sujal M. PatelCo-Founder, Chief Executive Officer, President, Secretary & Director536,2001975
Dr. Subra Sankar Ph.D.Senior Vice President of Product Development38,4731960
Mr. Kentaro SuzukiChief Marketing Officer143,4351970
Mr. Matthew B. Murphy ESQ.General Counsel382,6451965
Ms. Gwen E. WeldChief People Officer390,9681958
Dr. Parag Mallick Ph.D.Co-Founder, Chief Scientist & Director420,0001978
Ms. Anna MowryChief Financial Officer & Treasurer519,2121983

Description

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered in Seattle, Washington.